Benign Lesion Removal
Precision Treatment of Benign Skin Lesions Targeted ablative laser treatment for selected superficial benign skin lesions.
Benign Lesion Removal
Precision Treatment of Benign Skin Lesions
Targeted ablative laser treatment for selected superficial benign skin lesions.
Selected superficial benign skin lesions may be treated using ablative Er:YAG laser technology available on the Alma Harmony® platform. The Er:YAG laser delivers controlled energy to the superficial layers of the skin, allowing the clinician to ablate selected lesion tissue in a controlled and precise manner. Treatment is individualised according to the type, size, thickness, and location of the lesion.
A medical assessment is required before treatment to determine whether a lesion is appropriate for laser treatment.
Target Concerns
- Seborrhoeic keratoses
- Skin tags (acrochordons)
- Selected superficial benign epidermal lesions
- Selected raised benign lesions
- Other superficial lesions deemed suitable following clinical assessment
What to Expect Following assessment and confirmation of suitability, the selected lesion is treated with controlled ablative laser energy. Depending on the lesion and treatment depth, the treated area may appear red, raw, or develop a small crust during the healing process. The crust generally separates naturally as the skin heals. For superficial treatments, healing commonly occurs over approximately 7–14 days, although this can vary depending on the lesion, treatment depth, location, and individual healing response. Post-treatment care and strict sun protection are important to support healing and reduce the risk of post-inflammatory pigmentation.
Medical Assessment & Safety Not every skin lesion is suitable for laser treatment. All lesions require clinical assessment before treatment to determine whether they have features consistent with a benign lesion and whether laser treatment is appropriate. Any lesion that is suspicious, changing, atypical, or of uncertain diagnosis should not be treated cosmetically without appropriate medical evaluation. Where clinically indicated, further assessment, dermoscopy, biopsy, or histopathology may be required. Laser treatment should not be used as a substitute for diagnosis or histological examination where these are clinically indicated.
A medical assessment is required before treatment. The clinician will assess the lesion and determine whether it appears suitable for laser treatment or whether further investigation is required.
Discomfort varies depending on the lesion and treatment area. Topical anaesthetic may be used where appropriate to improve comfort.
Any ablative treatment carries a risk of scarring and pigmentary changes. The risk depends on factors including treatment depth, lesion characteristics, location, skin type, and individual healing. Your clinician will discuss potential risks during your consultation.
For superficial lesions, the treated area commonly develops a crust that naturally separates over approximately 7–14 days. Deeper or larger treatments may require longer healing.
The treated lesion may not recur once adequately removed, but recurrence can occur depending on the type of lesion and completeness of treatment. People who are prone to benign lesions may also develop new lesions elsewhere over time.
Laser ablation does not provide a tissue specimen for histopathological examination. If there is any clinical uncertainty or if histological diagnosis is required, biopsy or surgical removal may be recommended instead of laser treatment.
A medical assessment is required before treatment. The clinician will assess the lesion and determine whether it appears suitable for laser treatment or whether further investigation is required.
Discomfort varies depending on the lesion and treatment area. Topical anaesthetic may be used where appropriate to improve comfort.
Any ablative treatment carries a risk of scarring and pigmentary changes. The risk depends on factors including treatment depth, lesion characteristics, location, skin type, and individual healing. Your clinician will discuss potential risks during your consultation.
For superficial lesions, the treated area commonly develops a crust that naturally separates over approximately 7–14 days. Deeper or larger treatments may require longer healing.
The treated lesion may not recur once adequately removed, but recurrence can occur depending on the type of lesion and completeness of treatment. People who are prone to benign lesions may also develop new lesions elsewhere over time.
Laser ablation does not provide a tissue specimen for histopathological examination. If there is any clinical uncertainty or if histological diagnosis is required, biopsy or surgical removal may be recommended instead of laser treatment.